“Global cannabidiol market accelerates, powered by soaring adoption in health, beauty, and functional wellness sectors, and a global shift toward natural, plant-based solutions.”
Lifescience
“Global softgel capsules market surges, fueled by soaring wellness trends, expanding nutraceutical adoption, and innovation in bioavailable and convenient supplement formats.”
Softgel capsules are a specialized dosage form designed to deliver active ingredients in a liquid, semi-solid, or oil-based medium encapsulated within a gelatin or non-animal-based shell. This form offers several advantages over traditional tablets or powders, including ease of swallowing, the ability to mask unpleasant tastes and odors, enhanced absorption, improved bioavailability, and greater stability under various storage conditions. As a result, softgel capsules are preferred by consumers and manufacturers alike for delivering vitamins, minerals, herbal extracts, dietary supplements, and pharmaceutical drugs effectively. In the nutraceutical and dietary supplement segment, softgel capsules are employed to deliver essential vitamins such as vitamin D, vitamin E, and omega-3 fatty acids, as well as herbal extracts for immunity, cognitive support, and general wellness. In the pharmaceutical sector, they are used for targeted drug delivery, especially for compounds that are oil-soluble or have low water solubility, enabling better absorption in the gastrointestinal tract and faster therapeutic effects. The flexibility of the softgel format also allows for precise dosage, consistent quality, and a convenient form factor for consumers, increasing compliance with supplementation and medication regimens. The production and distribution of softgel capsules are strictly guided by regulatory frameworks and government policies, which ensure product safety, efficacy, and quality. Manufacturers must comply with Good Manufacturing Practices (GMP), adhere to stringent labeling requirements, and conduct rigorous safety and quality testing before releasing products to the market. These regulations are designed to protect consumers, prevent contamination, and maintain consistency in dosage, particularly for pharmaceuticals and high-potency nutraceuticals.
According to the research report "Global Softgel Capsules Market Outlook, 2030," published by Bonafide Research, the Global Softgel Capsules market was valued at more than USD 7.53 Billion in 2024, and expected to reach a market size of more than USD 11.55 Billion by 2030 with the CAGR of 7.54% from 2025-2030. The use of softgel capsules in cosmetics and personal care products is gaining traction due to their ability to encapsulate active ingredients and deliver them effectively. Opportunities in this segment include the development of innovative skincare and beauty supplements, addressing consumer demands for both internal and external beauty solutions. The veterinary market for softgel capsules is emerging as pet owners increasingly seek supplements for animal health. Opportunities exist in developing softgel formulations for pets that support joint health, skin and coat condition, and overall well-being. This growing segment reflects a broader trend towards pet health and wellness. The supply chain of softgel capsules involves several key stages, including raw material sourcing, manufacturing, packaging, and distribution. Raw materials such as gelatin, hydroxypropyl methylcellulose, and active pharmaceutical ingredients are sourced from various suppliers worldwide. Companies like Gelita AG , PB Leiner, and Nitta Gelatin are prominent suppliers of gelatin and other capsule materials. The import and export dynamics of softgel capsules are influenced by factors such as regulatory standards, manufacturing capabilities, and market demand. Countries with stringent regulatory frameworks, such as those in North America and Europe, often import softgel capsules to ensure compliance with local standards. New market entrants are focusing on innovative formulations and delivery systems to differentiate themselves in the competitive landscape. The development of plant-based softgel capsules using materials like HPMC and pullulan caters to the growing demand for vegan and vegetarian products. Advancements in capsule design, such as enteric-coated and delayed-release capsules, enhance the bioavailability and stability of active ingredients.
The Vitamins and Dietary Supplements segment is the leading and fastest-growing application in the Global Softgel Capsules Market because of a strong alignment between the technical advantages of softgel technology and powerful consumer health trends. Softgels are ideally suited for the nutraceutical industry, particularly for key ingredients like Omega-3 fatty acids, Vitamin D, and Vitamin E, which are often fat-soluble or oil-based. An increasing number of consumers worldwide are turning to supplements for immunity support, anti-aging, and overall wellness, a trend dramatically accelerated by recent global health events. This demand is further amplified by significant demographic factors, such as the aging global population, where older individuals prefer the ease of ingestion offered by softgels. From a manufacturing perspective, softgels also provide superior protection for sensitive vitamins and oils. Their hermetically sealed shell creates an effective barrier against light, oxygen, and moisture, which helps extend the product's shelf life and maintain the potency of the active ingredients, providing a quality guarantee that resonates with health-conscious consumers. In recent years, consumers have become more health-conscious, leading to a surge in the use of vitamins, minerals, and dietary supplements to support immunity, energy, bone strength, and overall well-being. Softgel capsules have emerged as the preferred delivery format for these supplements because they offer superior absorption, easy consumption, and enhanced product stability compared to tablets or powders.
The Non-Animal-Based softgel capsule segment is witnessing the fastest growth in the global market as consumers increasingly shift toward plant-derived and sustainable alternatives in their dietary and pharmaceutical products. This trend is primarily driven by the growing global preference for vegan and vegetarian lifestyles, coupled with heightened awareness of animal welfare, religious restrictions, and environmental sustainability. Today’s consumers are more informed and conscious about what they consume, preferring products with transparent ingredient lists, no animal derivatives, and minimal synthetic additives. Non-animal-based softgels perfectly fit this demand by offering clean-label, allergen-free, and halal- or kosher-compliant formulations. The pharmaceutical and nutraceutical industries are also adopting non-animal-based softgels due to their compatibility with a wide range of bioactive compounds and suitability for encapsulating plant oils, herbal extracts, and essential nutrients. Manufacturers are leveraging advanced encapsulation technologies to enhance the performance and stability of these capsules, ensuring they match or even exceed the quality standards of traditional gelatin softgels. The production of plant-based materials typically has a lower environmental footprint compared to animal-based gelatin, which relies on livestock-derived raw materials. As the global focus on reducing carbon emissions and promoting eco-friendly manufacturing intensifies, companies are increasingly shifting toward sustainable capsule materials to align with corporate social responsibility (CSR) goals and green production standards.
Pharmaceutical companies dominate the global softgel capsules market because softgels offer a highly effective and reliable form of drug delivery for a wide range of therapeutic compounds. Unlike tablets or powders, softgel capsules can encapsulate liquid, semi-solid, or oil-based formulations, which ensures faster absorption and higher bioavailability of the active pharmaceutical ingredients (APIs). One of the biggest advantages of softgel capsules for pharmaceuticals is their ability to improve patient compliance. They are smooth, tasteless, and easy to swallow, which makes them more acceptable to patients compared to large or bitter tablets. This is especially important in long-term therapies or among elderly and pediatric populations who often struggle with traditional dosage forms. pharmaceutical companies benefit from the stability and protection provided by softgel capsules. The gelatin or non-animal-based outer shell forms an airtight barrier that shields the contents from oxygen, moisture, and light factors that can degrade the potency of active ingredients. Softgel capsules also support formulation flexibility, allowing pharmaceutical manufacturers to develop innovative products. They can be designed for immediate, delayed, or sustained release, depending on the therapeutic need. This makes softgels suitable for various treatment categories, including pain management, cardiovascular health, hormonal therapies, and neurological disorders. the compatibility of softgels with lipid-based formulations enables the effective delivery of poorly water-soluble drugs a key advantage that has led to their growing use in modern drug development.
According to the research report "Global Softgel Capsules Market Outlook, 2030," published by Bonafide Research, the Global Softgel Capsules market was valued at more than USD 7.53 Billion in 2024, and expected to reach a market size of more than USD 11.55 Billion by 2030 with the CAGR of 7.54% from 2025-2030. The use of softgel capsules in cosmetics and personal care products is gaining traction due to their ability to encapsulate active ingredients and deliver them effectively. Opportunities in this segment include the development of innovative skincare and beauty supplements, addressing consumer demands for both internal and external beauty solutions. The veterinary market for softgel capsules is emerging as pet owners increasingly seek supplements for animal health. Opportunities exist in developing softgel formulations for pets that support joint health, skin and coat condition, and overall well-being. This growing segment reflects a broader trend towards pet health and wellness. The supply chain of softgel capsules involves several key stages, including raw material sourcing, manufacturing, packaging, and distribution. Raw materials such as gelatin, hydroxypropyl methylcellulose, and active pharmaceutical ingredients are sourced from various suppliers worldwide. Companies like Gelita AG , PB Leiner, and Nitta Gelatin are prominent suppliers of gelatin and other capsule materials. The import and export dynamics of softgel capsules are influenced by factors such as regulatory standards, manufacturing capabilities, and market demand. Countries with stringent regulatory frameworks, such as those in North America and Europe, often import softgel capsules to ensure compliance with local standards. New market entrants are focusing on innovative formulations and delivery systems to differentiate themselves in the competitive landscape. The development of plant-based softgel capsules using materials like HPMC and pullulan caters to the growing demand for vegan and vegetarian products. Advancements in capsule design, such as enteric-coated and delayed-release capsules, enhance the bioavailability and stability of active ingredients.
The Vitamins and Dietary Supplements segment is the leading and fastest-growing application in the Global Softgel Capsules Market because of a strong alignment between the technical advantages of softgel technology and powerful consumer health trends. Softgels are ideally suited for the nutraceutical industry, particularly for key ingredients like Omega-3 fatty acids, Vitamin D, and Vitamin E, which are often fat-soluble or oil-based. An increasing number of consumers worldwide are turning to supplements for immunity support, anti-aging, and overall wellness, a trend dramatically accelerated by recent global health events. This demand is further amplified by significant demographic factors, such as the aging global population, where older individuals prefer the ease of ingestion offered by softgels. From a manufacturing perspective, softgels also provide superior protection for sensitive vitamins and oils. Their hermetically sealed shell creates an effective barrier against light, oxygen, and moisture, which helps extend the product's shelf life and maintain the potency of the active ingredients, providing a quality guarantee that resonates with health-conscious consumers. In recent years, consumers have become more health-conscious, leading to a surge in the use of vitamins, minerals, and dietary supplements to support immunity, energy, bone strength, and overall well-being. Softgel capsules have emerged as the preferred delivery format for these supplements because they offer superior absorption, easy consumption, and enhanced product stability compared to tablets or powders.
The Non-Animal-Based softgel capsule segment is witnessing the fastest growth in the global market as consumers increasingly shift toward plant-derived and sustainable alternatives in their dietary and pharmaceutical products. This trend is primarily driven by the growing global preference for vegan and vegetarian lifestyles, coupled with heightened awareness of animal welfare, religious restrictions, and environmental sustainability. Today’s consumers are more informed and conscious about what they consume, preferring products with transparent ingredient lists, no animal derivatives, and minimal synthetic additives. Non-animal-based softgels perfectly fit this demand by offering clean-label, allergen-free, and halal- or kosher-compliant formulations. The pharmaceutical and nutraceutical industries are also adopting non-animal-based softgels due to their compatibility with a wide range of bioactive compounds and suitability for encapsulating plant oils, herbal extracts, and essential nutrients. Manufacturers are leveraging advanced encapsulation technologies to enhance the performance and stability of these capsules, ensuring they match or even exceed the quality standards of traditional gelatin softgels. The production of plant-based materials typically has a lower environmental footprint compared to animal-based gelatin, which relies on livestock-derived raw materials. As the global focus on reducing carbon emissions and promoting eco-friendly manufacturing intensifies, companies are increasingly shifting toward sustainable capsule materials to align with corporate social responsibility (CSR) goals and green production standards.
Pharmaceutical companies dominate the global softgel capsules market because softgels offer a highly effective and reliable form of drug delivery for a wide range of therapeutic compounds. Unlike tablets or powders, softgel capsules can encapsulate liquid, semi-solid, or oil-based formulations, which ensures faster absorption and higher bioavailability of the active pharmaceutical ingredients (APIs). One of the biggest advantages of softgel capsules for pharmaceuticals is their ability to improve patient compliance. They are smooth, tasteless, and easy to swallow, which makes them more acceptable to patients compared to large or bitter tablets. This is especially important in long-term therapies or among elderly and pediatric populations who often struggle with traditional dosage forms. pharmaceutical companies benefit from the stability and protection provided by softgel capsules. The gelatin or non-animal-based outer shell forms an airtight barrier that shields the contents from oxygen, moisture, and light factors that can degrade the potency of active ingredients. Softgel capsules also support formulation flexibility, allowing pharmaceutical manufacturers to develop innovative products. They can be designed for immediate, delayed, or sustained release, depending on the therapeutic need. This makes softgels suitable for various treatment categories, including pain management, cardiovascular health, hormonal therapies, and neurological disorders. the compatibility of softgels with lipid-based formulations enables the effective delivery of poorly water-soluble drugs a key advantage that has led to their growing use in modern drug development.
Related Press Releases
Quick Contacts
Trusted Partners
Latest Press Release
We are friendly and approachable, give us a call.